- About |
- Contact Us |
- Site Map |
- Privacy Policy |
- Terms Of Use |
- Feedback
72. Ensuring Supplies of Appropriate Drugs and Vaccines
CUSTOM BOOKS
Select, organize, download, and save your choice of chapters into a single PDF file for printing and distribution. This is a free service.
My DCPP
Log in to view your saved custom books
CHAPTER INFO
Editors/Authors: Susan Foster, Richard Laing, Bjørn Melgaard, and Michel Zaffran
Pages: 16
Region
East Asia and Pacific
High Income OECD
Latin America and the Caribbean
South Asia
Sub-Saharan Africa
Disease / Condition
Adolescent & Childhood Diseases
HIV/AIDS
Malaria
Maternal & Neonatal Conditions
Maternal Conditions
Neonatal Conditions
Noncommunicable Diseases
Respiratory Diseases
Tropical Diseases
Tuberculosis
Vaccine-Preventable Diseases
Abstract
Although access to essential medicines in developing countries has improved significantly in recent years, 30 percent of the world's population still has no effective access to modern drugs or vaccines. The majority of these people are extremely poor or living in remote rural areas.
Ensuring that needed essential medicines and vaccines are available is critical for the success of any disease control program. Important components of a supply system include careful selection of a short list of the most needed drugs and vaccines, procurement from qualified suppliers, proper storage and distribution using secure, reliable channels, and assurance of rational use and correct dispensing.
The World Health Organization (WHO) has set standards and norms for the selection and use of vaccines; however, where other pharmaceuticals are concerned, problems exist in procurement, quality assurance, and management of large stocks of donated drugs. Problems also exist in drug dispensing: for example, drugs dispensed by untrained staff members to patients who do not understand the drug's purpose can go to waste. The presence of "dispensing doctors" whose income depends on how much they prescribe has been associated with a failure to follow accepted guidelines.
Depending on the circumstances, either the public or private sector, or a combination of both, can efficiently deliver quality–assured medicines and vaccines. Essential medicines and vaccines can be reliably delivered to poor people using approaches that include bulk purchases of generic drugs, procurement from nonprofit suppliers, purchase of WHO–prequalified products, and use of private transporters or computerized systems to lower delivery costs and improve management of logistics.
Sections
Click on the links below to read the full text.
- Intro
- Drug Policies
- Vaccine Policies
- Selection of Drugs
- Selection of Vaccines
- Procurement of Drugs
- Procurement of Vaccines
- Quality Assurance for Pharmaceuticals and Vaccines
- The WHO Prequalification Schemes
- Local Production of Pharmaceuticals
- Storage and Distribution of Essential Drugs and Vaccines
- Prescription and Rational Use of Drugs
- Dispensing
- Adherence
- Financing Issues
- Sustainable Financing of Vaccines and Immunizations
- Issues for the Future
- Vaccine Research Priorities
- Priorities for Pharmaceutical Research
- Conclusion
- References
Tables
- 72.1 Current Vaccines Recommended by the World Health Organization
-
72.2
Measured World Pharmaceutical Spending, by Per Capita Income Clusters, 1990-2000
(percent) - 72.3 Trends and Developments in Financing and Procurement of Essential Drugs, Vaccines, and Contraceptives
- 72.4 New Vaccines Needed
- 72.5 Preliminary List of 16 Priority Areas for Pharmaceutical Research
